SCHEMBL5685461

SCHEMBL5685461

OC1=NC(O)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8171368 0.65
SCHEMBL11190048 0.64 NOS1 (0.36)
SCHEMBL5049668 0.62
SCHEMBL1083170 0.61
SCHEMBL5514042 0.52
SCHEMBL4058540 0.52 THRB (0.30)
SCHEMBL27209141 0.52 THRB (0.30)
SCHEMBL27209144 0.52 THRB (0.30)
SCHEMBL11720388 0.51
SCHEMBL5406262 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224177-B1 PROCESS FOR PREPARING OXAZOLINES FROM TETRAHYDROFURANS AGOURON PHARMA (US) 2004-02-11 EP claimed
US-20030023092-A1 Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors BORER BENNETT C (US) 2003-01-30 US claimed
US-6472534-B2 TREATING TETRAHYDROFURAN DERIVATIV WITH AN OXOPHILIC ELECTROPHILIC REAGENT IN A MANNER THAT IS EFFECTIVE TO PROVIDE THE OXAZOLINE COMPOUND AGOURON PHARMACEUTICALS, INC. 2002-10-29 US claimed
EP-1224177-A1 PROCESS FOR PREPARING OXAZOLINES FROM TETRAHYDROFURANS AGOURON PHARMACEUTICALS, INC. (US) 2002-07-24 EP claimed
US-20020038033-A1 Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors BORER BENNETT C (US) 2002-03-28 US claimed
WO-2001029013-A1 PROCESS FOR PREPARING OXAZOLINES FROM TETRAHYDROFURANS AGOURON PHARMACEUTICALS, INC. (US) 2001-04-26 WO claimed
CN-102757684-B Bei replaces oxazoline compound or Bei replaces oxazoline derivant Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) 2015-11-18 CN disclosed
CN-102757679-B Comprise Bei and replace the ink composite that oxazoline compound or Bei replace oxazoline derivant Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) 2015-10-28 CN disclosed
US-9109124-B2 Solid ink compositions comprising semicrystalline oligomer resins XEROX CORPORATION (US) 2015-08-18 US disclosed
US-9044512-B2 Amino alcohol cationic lipids for oligonucleotide delivery SIRNA THERAPEUTICS, INC. (US) 2015-06-02 US disclosed
US-20140323548-A1 NOVEL AMINO ALCOHOL CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY BANK OF AMERICA, N.A. 2014-10-30 US disclosed
US-8802863-B2 Amino alcohol cationic lipids for oligonucleotide delivery SIRNA THERAPEUTICS, INC. (US) 2014-08-12 US disclosed
US-8500260-B2 Ink compositions incorporating substituted oxazoline compounds or substituted oxazoline derivatives XEROX CORPORATION (US) 2013-08-06 US disclosed
WO-2001066536-A1 PROCESS FOR THE PREPARATION OF CITALOPRAM RESOLUTION CHEMICALS LIMITED (GB) 2001-09-13 WO disclosed
WO-2001029013-A1 PROCESS FOR PREPARING OXAZOLINES FROM TETRAHYDROFURANS AGOURON PHARMACEUTICALS, INC. (US) 2001-04-26 WO disclosed
US-5827868-A Prostaglandin analogs E. R. SQUIBB & SONS, INC. (US) 1998-10-27 US disclosed
EP-0536713-A1 Oxazole and imidazole derivatives as prostaglandin analogs E.R. SQUIBB &amp; SONS, INC. (US) 1993-04-14 EP disclosed
US-4780405-A Carbonic anhydrase inhibitor-tagged nucleic acid probes SISKA DIAGNOSTICS, INC. (US) 1988-10-25 US disclosed
EP-0210021-A2 Carbonic anhydrase inhibitor-tagged nucleic acid probes SISKA DIAGNOSTICS,INC. (US) 1987-01-28 EP disclosed
US-4042546-A Reactive polyester-amide polymers as co-reactants or curing agents for polyepoxides and polyisocyanates SIMON ELI 1977-08-16 US disclosed